癌症患者疑似与意外肺栓塞的临床特征及短期结局:EPIPHANY研究
EPIPHANY多中心观察性研究纳入1033例连续肺栓塞癌症患者,分析30天全因死亡预测因素。总体30天死亡率为14%,真正无症状意外肺栓塞患者死亡率3%,显著低于有症状意外肺栓塞(20%)和疑似肺栓塞(21%)。与癌症和肺栓塞严重性相关的变量与短期死亡相关。
要点
- 癌症合并肺栓塞患者总体30天死亡率为14%。
- 真正无症状意外肺栓塞30天死亡率3%,显著低于有症状意外肺栓塞20%和疑似肺栓塞21%。
- VTE史、上消化道癌、转移、癌症进展、体能状态、低血压、心率快、低氧饱和度及疑似肺栓塞与30天死亡相关。
核心结论
- 与癌症和肺栓塞严重性相关的变量与短期死亡相关,可能有助于建立该人群肺栓塞风险评估模型。
研究设计与样本
- 多中心观察性双向性EPIPHANY研究(2006年3月至2014年10月),纳入1033例连续肺栓塞癌症患者。
- 其中497例前瞻性评估患者按检查场景分为疑似肺栓塞、真正无症状意外肺栓塞和有症状意外肺栓塞三组评估结局。
主要发现
- 总体30天死亡率为14%。
- 多因素分析显示VTE史、上消化道癌、转移性疾病、癌症进展、体能状态、动脉低血压<100 mmHg、心率>110次·分-1、基础氧饱和度<90%及疑似肺栓塞(对比总体意外肺栓塞)与总体30天死亡相关。
- 真正无症状意外肺栓塞30天死亡率3%,有症状意外肺栓塞20%,疑似肺栓塞21%,组间差异显著(p<0.0001)。
- 30天和90天VTE复发率及大出血率在各组间相似。
临床怎么用
- 对癌症合并肺栓塞患者应关注癌症严重性及肺栓塞严重性相关变量以评估短期死亡风险。
- 真正无症状意外肺栓塞患者短期死亡风险较低,有症状意外肺栓塞和疑似肺栓塞患者风险较高。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The study aimed to identify predictors of overall 30-day mortality in cancer patients with pulmonary embolism including suspected pulmonary embolism (SPE) and unsuspected pulmonary embolism (UPE) events. Secondary outcomes included 30- and 90-day major bleeding and venous thromboembolism (VTE) recurrence.The study cohort included 1033 consecutive patients with pulmonary embolism from the multicentre observational ambispective EPIPHANY study (March 2006-October 2014). A subgroup of 497 patients prospectively assessed for the study were subclassified into three work-up scenarios (SPE, truly asymptomatic UPE and UPE with symptoms) to assess outcomes.The overall 30-day mortality rate was 14%. The following variables were associated with the overall 30-day mortality on multivariate analysis: VTE history, upper gastrointestinal cancers, metastatic disease, cancer progression, performance status, arterial hypotension <100 mmHg, heart rate >110 beats·min-1, basal oxygen saturation <90% and SPE (versus overall UPE).The overall 30-day mortality was significantly lower in patients with truly asymptomatic UPE events (3%) compared with those with UPE-S (20%) and SPE (21%) (p<0.0001). Thirty- and 90-day VTE recurrence and major bleeding rates were similar in all the groups.In conclusion, variables associated with the severity of cancer and pulmonary embolism were associated with short-term mortality. Our findings may help to develop pulmonary embolism risk-assessment models in this setting.
引用
- Font C, Carmona-Bayonas A, Beato C, et al. Clinical features and short-term outcomes of cancer patients with suspected and unsuspected pulmonary embolism: the EPIPHANY study. Eur Respir J. 2017. PMID: 28052954. doi:10.1183/13993003.00282-2016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。